main content start
Rezvoglar (insulin glargine-aglr) injection is a long-acting insulin for adults and children with diabetes. It is injected once a day via a prefilled disposable Rezvoglar KwikPen. It is a biosimilar (or near-identical copy) of Lantus.
- Long-acting insulin: Covers full day insulin needs. Usually begins to work several hours after injection and lasts for up to 24 hours.
- It is injected once a day via a prefilled disposable Rezvoglar KwikPen.
- Approved for adults and children with diabetes.
- It is a biosimilar (or near-identical copy) of Lantus.
- Rezvoglar KwikPen is a light gray pen. It delivers doses in 1 unit increments, up to 80 units at a time. It has a total capacity of 300 units.
Rezvoglar KwikPen Specs
Key specification
Generic Name
Insulin glargine-aglr
Onset
Not Applicable
Peak
No peak
Duration
24 hours
Approved for Kids
Yes
Color
Light gray
Concentration
U-100
Delivery
Pen
Insulin Type
Long-acting
Form
Biosimilar
General Information
Product Name
Rezvoglar KwikPen
Product Type
Insulin
Brand
Eli Lilly and Co.
Other Devices & Supplies
Looking for a different way to manage diabetes care? Browse and compare information on the latest devices, tools, and technology.
